James I Hudson

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. doi A structural approach to the familial coaggregation of disorders
    James I Hudson
    Biological Psychiatry Laboratory, McLean Hospital, Belmont, MA 02478, USA
    Epidemiology 19:431-9. 2008
  2. pmc Features of men with anabolic-androgenic steroid dependence: A comparison with nondependent AAS users and with AAS nonusers
    Gen Kanayama
    Biological Psychiatry Laboratory, McLean Hospital Harvard Medical School, 115 Mill Street, Belmont, MA 02478, United States
    Drug Alcohol Depend 102:130-7. 2009
  3. ncbi Family study of affective spectrum disorder
    James I Hudson
    Department of Psychiatry, Harvard Medical School, Boston, Mass, USA
    Arch Gen Psychiatry 60:170-7. 2003
  4. pmc The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication
    James I Hudson
    Department of Psychiatry, Harvard Medical School and Biological Psychiatry Laboratory, McLean Hospital, Belmont, Massachusetts 02478, USA
    Biol Psychiatry 61:348-58. 2007
  5. ncbi Binge-eating disorder as a distinct familial phenotype in obese individuals
    James I Hudson
    Department of Psychiatry, Harvard Medical School and McLean Hospital, Belmont, Mass 02478, USA
    Arch Gen Psychiatry 63:313-9. 2006
  6. pmc Duloxetine in the treatment of major depressive disorder: an open-label study
    James I Hudson
    McLean Hospital, Belmont, MA, USA
    BMC Psychiatry 7:43. 2007
  7. ncbi The cross-sectional cohort study: an underutilized design
    James I Hudson
    Biological Psychiatry Laboratory, McLean Hospital, 115 Mill Street, Belmont, MA 02478, USA
    Epidemiology 16:355-9. 2005
  8. ncbi Genetic epidemiology of eating disorders and co-occurring conditions: the role of endophenotypes
    James I Hudson
    Biological Psychiatry Laboratory, McLean Hospital, Belmont, MA 02478, USA
    Int J Eat Disord 40:S76-8. 2007
  9. pmc Longitudinal study of the diagnosis of components of the metabolic syndrome in individuals with binge-eating disorder
    James I Hudson
    McLean Hospital, Belmont, MA 02478, USA
    Am J Clin Nutr 91:1568-73. 2010
  10. ncbi Family study of fibromyalgia and affective spectrum disorder
    James I Hudson
    Biological Psychiatry Laboratory, McLean Hospital Department of Psychiatry, Harvard Medical School, Belmont, MA 02478, USA
    Biol Psychiatry 56:884-91. 2004

Detail Information

Publications71

  1. doi A structural approach to the familial coaggregation of disorders
    James I Hudson
    Biological Psychiatry Laboratory, McLean Hospital, Belmont, MA 02478, USA
    Epidemiology 19:431-9. 2008
    ..For illustration, we applied our method to a family study of binge eating disorder and bipolar disorder...
  2. pmc Features of men with anabolic-androgenic steroid dependence: A comparison with nondependent AAS users and with AAS nonusers
    Gen Kanayama
    Biological Psychiatry Laboratory, McLean Hospital Harvard Medical School, 115 Mill Street, Belmont, MA 02478, United States
    Drug Alcohol Depend 102:130-7. 2009
    ..Anabolic-androgenic steroid (AAS) dependence has been a recognized syndrome for some 20 years, but remains poorly understood...
  3. ncbi Family study of affective spectrum disorder
    James I Hudson
    Department of Psychiatry, Harvard Medical School, Boston, Mass, USA
    Arch Gen Psychiatry 60:170-7. 2003
    ..Two predictions of the ASD hypothesis were tested: that ASD, taken as a single entity, would aggregate in families and that MDD would coaggregate with other forms of ASD in families...
  4. pmc The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication
    James I Hudson
    Department of Psychiatry, Harvard Medical School and Biological Psychiatry Laboratory, McLean Hospital, Belmont, Massachusetts 02478, USA
    Biol Psychiatry 61:348-58. 2007
    ..Little population-based data exist on the prevalence or correlates of eating disorders...
  5. ncbi Binge-eating disorder as a distinct familial phenotype in obese individuals
    James I Hudson
    Department of Psychiatry, Harvard Medical School and McLean Hospital, Belmont, Mass 02478, USA
    Arch Gen Psychiatry 63:313-9. 2006
    ..However, it remains unclear whether BED represents an etiologically distinct behavioral phenotype of obesity or simply a nonspecific eating pattern sometimes seen in obese individuals...
  6. pmc Duloxetine in the treatment of major depressive disorder: an open-label study
    James I Hudson
    McLean Hospital, Belmont, MA, USA
    BMC Psychiatry 7:43. 2007
    ..In this study, the safety and efficacy of duloxetine, a potent dual reuptake inhibitor of 5-HT and NE, were examined...
  7. ncbi The cross-sectional cohort study: an underutilized design
    James I Hudson
    Biological Psychiatry Laboratory, McLean Hospital, 115 Mill Street, Belmont, MA 02478, USA
    Epidemiology 16:355-9. 2005
    ..Such situations often arise when studying chronic or episodic conditions with low mortality, such as psychiatric disorders...
  8. ncbi Genetic epidemiology of eating disorders and co-occurring conditions: the role of endophenotypes
    James I Hudson
    Biological Psychiatry Laboratory, McLean Hospital, Belmont, MA 02478, USA
    Int J Eat Disord 40:S76-8. 2007
  9. pmc Longitudinal study of the diagnosis of components of the metabolic syndrome in individuals with binge-eating disorder
    James I Hudson
    McLean Hospital, Belmont, MA 02478, USA
    Am J Clin Nutr 91:1568-73. 2010
    ..Binge-eating disorder may represent a risk factor for the metabolic syndrome...
  10. ncbi Family study of fibromyalgia and affective spectrum disorder
    James I Hudson
    Biological Psychiatry Laboratory, McLean Hospital Department of Psychiatry, Harvard Medical School, Belmont, MA 02478, USA
    Biol Psychiatry 56:884-91. 2004
    ..Two predictions of the ASD hypothesis were tested: ASD, taken as a single entity, aggregates in families; and fibromyalgia coaggregates with other forms of ASD in families...
  11. doi By how much will the proposed new DSM-5 criteria increase the prevalence of binge eating disorder?
    James I Hudson
    Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA
    Int J Eat Disord 45:139-41. 2012
    ..To estimate how much the prevalence of binge eating disorder will increase under the new proposed DSM-5 criteria, which relax the requirements for the frequency and duration of eating binges...
  12. ncbi Comorbidity of fibromyalgia and psychiatric disorders
    Lesley M Arnold
    Women s Health Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, Ohio 45219, USA
    J Clin Psychiatry 67:1219-25. 2006
    ..To assess the co-occurrence of fibromyalgia with psychiatric disorders in participants of a fibromyalgia family study...
  13. ncbi Binge eating disorder: a stable syndrome
    Harrison G Pope
    Department of Psychiatry, Harvard Medical School and McLean Hospital, Belmont, MA 02478, USA
    Am J Psychiatry 163:2181-3. 2006
    ..This study assessed the stability of binge eating disorder in a community sample...
  14. ncbi Topiramate in the long-term treatment of binge-eating disorder associated with obesity
    Susan L McElroy
    Psychopharmacology Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267 0559, USA
    J Clin Psychiatry 65:1463-9. 2004
    ..This study assessed the long-term effectiveness and tolerability of topiramate in binge-eating disorder (BED) with obesity...
  15. ncbi Co-occurrence of binge eating disorder with psychiatric and medical disorders
    Kristin N Javaras
    Department of Biostatistics, Harvard School of Public Health, Boston, Mass, USA
    J Clin Psychiatry 69:266-73. 2008
    ..We used data from that type of study to assess the co-occurrence of various psychiatric and medical disorders with DSM-IV BED and with subthreshold BED...
  16. pmc Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs
    John H Halpern
    Laboratory for Integrative Psychiatry Biological Psychiatry Laboratory Cognitive and Clinical Neuroimaging Core Brain Imaging Center McLean Hospital, Belmont, MA, USA
    Addiction 106:777-86. 2011
    ..We designed an investigation seeking to minimize these possible sources of bias...
  17. doi Lamotrigine in the treatment of binge-eating disorder with obesity: a randomized, placebo-controlled monotherapy trial
    Anna I Guerdjikova
    Department of Psychiatry, University of Cincinnati College of Medicine, Lindner Center of HOPE, Mason, Ohio 45040, USA
    Int Clin Psychopharmacol 24:150-8. 2009
    ..As a result of an exceptionally high placebo response, it is likely that for efficacy measures except for body weight and metabolic indices, the study was incapable of detecting potentially clinically important drug-placebo difference...
  18. pmc Family history study of the familial coaggregation of borderline personality disorder with axis I and nonborderline dramatic cluster axis II disorders
    Mary C Zanarini
    Laboratory for the Study for Adult Development and the Psychiatric Epidemiology Research Program, McLean Hospital, and the Department of Psychiatry, Harvard Medical School, USA
    J Pers Disord 23:357-69. 2009
    ..Taken together, the results of this study suggest that common familial factors, particularly in the areas of affective disturbance and impulsivity, contribute to borderline personality disorder...
  19. ncbi Efficacy of sibutramine for the treatment of binge eating disorder: a randomized multicenter placebo-controlled double-blind study
    Denise E Wilfley
    Department of Psychiatry, Washington University School of Medicine, St Louis, MO 63110, USA
    Am J Psychiatry 165:51-8. 2008
    ..This study is the first large-scale, multisite, placebo-controlled trial to test the efficacy of sibutramine in binge eating disorder...
  20. ncbi Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial
    Susan L McElroy
    Psychopharmacology Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, OH 45267 0559, USA
    J Clin Psychiatry 67:1897-906. 2006
    ..Binge eating disorder (BED) is associated with obesity. Zonisamide is a novel antiepileptic drug associated with weight loss. The purpose of this study was to evaluate zonisa-mide in the treatment of BED associated with obesity...
  21. ncbi Citalopram in the treatment of binge-eating disorder: a placebo-controlled trial
    Susan L McElroy
    Division of Psychopharmacology Research and Eating Disorders, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267 0559, USA
    J Clin Psychiatry 64:807-13. 2003
    ..Citalopram is a highly selective serotonin reuptake inhibitor antidepressant. The purpose of this study was to assess the efficacy and safety of citalopram in the treatment of binge-eating disorder...
  22. pmc Risk factors for illicit anabolic-androgenic steroid use in male weightlifters: a cross-sectional cohort study
    Harrison G Pope
    Biological Psychiatry Laboratory, McLean Hospital, Belmont, Massachusetts 02478, USA
    Biol Psychiatry 71:254-61. 2012
    ..Almost all AAS abusers are male and lift weights, but the risk factors for AAS use among male weightlifters remain poorly understood...
  23. doi Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder
    Lesley M Arnold
    Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, OH, USA
    Clin J Pain 25:461-8. 2009
    ..To investigate whether comorbid major depressive disorder (MDD) influenced the efficacy and safety of duloxetine in treating fibromyalgia (FM)...
  24. ncbi Duloxetine in the treatment of irritable bowel syndrome: an open-label pilot study
    Brian P Brennan
    Biological Psychiatry Laboratory, McLean Hospital, Belmont, Massachusetts 02478, USA
    Hum Psychopharmacol 24:423-8. 2009
    ..To assess the efficacy of duloxetine for irritable bowel syndrome (IBS)...
  25. doi What makes patients with fibromyalgia feel better? Correlations between Patient Global Impression of Improvement and changes in clinical symptoms and function: a pooled analysis of 4 randomized placebo-controlled trials of duloxetine
    James I Hudson
    Harvard Medical School McLean Hospital, Belmont, Massachusetts, USA
    J Rheumatol 36:2517-22. 2009
    ..To investigate the relationship between changes in clinical rating scale items and endpoint Patient Global Impression of Improvement (PGI-I)...
  26. doi A placebo-controlled trial of acetyl-L-carnitine and α-lipoic acid in the treatment of bipolar depression
    Brian P Brennan
    Biological Psychiatry Laboratory, McLean Hospital, Belmont, MA 02478, USA
    J Clin Psychopharmacol 33:627-35. 2013
    ....
  27. pmc Cognitive deficits in long-term anabolic-androgenic steroid users
    Gen Kanayama
    Biological Psychiatry Laboratory, McLean Hospital, Belmont, MA 02478, USA
    Drug Alcohol Depend 130:208-14. 2013
    ..These findings raise the possibility, apparently still untested, that humans using high-dose AAS might eventually develop cognitive deficits...
  28. ncbi Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial
    Susan L McElroy
    Division of Psychopharmacology Research, Department of Psychiatry, University of Cincinnati College of Medicine, OH 45267 0559, USA
    Am J Psychiatry 160:255-61. 2003
    ..Binge eating disorder is associated with obesity. Topiramate is an antiepileptic agent associated with weight loss. The objective of this study was to evaluate topiramate in the treatment of binge eating disorder associated with obesity...
  29. ncbi High-dose escitalopram in the treatment of binge-eating disorder with obesity: a placebo-controlled monotherapy trial
    Anna I Guerdjikova
    Division of Psychopharmacology Research, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267 0559, USA
    Hum Psychopharmacol 23:1-11. 2008
    ..The purpose of this study was to evaluate the efficacy and safety of high-dose escitalopram in the treatment of binge-eating disorder (BED) associated with obesity...
  30. ncbi Atomoxetine in the treatment of binge-eating disorder: a randomized placebo-controlled trial
    Susan L McElroy
    Psychopharmacology Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, OH 45267 0559, USA
    J Clin Psychiatry 68:390-8. 2007
    ..Binge-eating disorder (BED) is associated with obesity. Atomoxetine is a highly selective norepinephrine reuptake inhibitor associated with weight loss. The purpose of this study was to evaluate atomoxetine in the treatment of BED...
  31. pmc Treatment of anabolic-androgenic steroid dependence: Emerging evidence and its implications
    Gen Kanayama
    Biological Psychiatry Laboratory, McLean Hospital, Belmont, MA, USA
    Drug Alcohol Depend 109:6-13. 2010
    ..Indeed, the opioid antagonist naltrexone blocks AAS dependence in animals. By inference, pharmacological and psychosocial treatments for human opioid dependence might also benefit AAS-dependent individuals...
  32. ncbi A placebo-controlled, randomized trial of fluoxetine in the treatment of binge-eating disorder
    Lesley M Arnold
    Women s Health Research Program, Department of Psychiatry, University of Cincinnati Medical Center, Cincinnati, Ohio, USA
    J Clin Psychiatry 63:1028-33. 2002
    ..The purpose of this study was to assess the efficacy and safety of fluoxetine in the treatment of binge-eating disorder...
  33. ncbi Body image and attitudes toward male roles in anabolic-androgenic steroid users
    Gen Kanayama
    McLean Hospital, 115 Mill St, Belmont, MA 02478, USA
    Am J Psychiatry 163:697-703. 2006
    ..In particular, the authors compared current versus past AAS users and short-term versus long-term users in this respect...
  34. ncbi Parallel-group placebo-controlled trial of testosterone gel in men with major depressive disorder displaying an incomplete response to standard antidepressant treatment
    Harrison G Pope
    Biological Psychiatry Laboratory, McLean Hospital, Belmont, MA 02478, USA
    J Clin Psychopharmacol 30:126-34. 2010
    ..The possibility remains that testosterone might benefit a particular subgroup of depressed men, but if so, the characteristics of this subgroup would still need to be established...
  35. ncbi Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial
    Lesley M Arnold
    University of Cincinnati College of Medicine, Cincinnati, Ohio 45219, and Newton Wellesley Hospital, Newton, MA, USA
    Arthritis Rheum 56:1336-44. 2007
    ..To assess the efficacy and safety of gabapentin in patients with fibromyalgia...
  36. ncbi Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study
    Susan L McElroy
    Psychopharmacology Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267 0559, USA
    Biol Psychiatry 61:1039-48. 2007
    ..The current investigation evaluated the safety and efficacy of topiramate in a multicenter, placebo-controlled trial...
  37. ncbi Memantine in the treatment of binge eating disorder: an open-label, prospective trial
    Brian P Brennan
    Biological Psychiatry Laboratory, McLean Hospital, Belmont, MA 02478, USA
    Int J Eat Disord 41:520-6. 2008
    ..To assess preliminarily the efficacy of memantine in binge eating disorder...
  38. ncbi Zonisamide in the treatment of binge-eating disorder: an open-label, prospective trial
    Susan L McElroy
    Division of Clinical Neuroscience, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA
    J Clin Psychiatry 65:50-6. 2004
    ..It commonly co-occurs with obesity. Zonisamide is a novel antiepileptic drug associated with weight loss. The purpose of this study was to preliminarily assess zonisamide in the treatment of binge-eating disorder...
  39. ncbi The subsyndromal phenomenology of borderline personality disorder: a 10-year follow-up study
    Mary C Zanarini
    Laboratory for the Study of Adult Development and the Psychiatric Epidemiology Research Program, McLean Hospital, 115 Mill St, Belmont 02478, and the Department of Psychiatry, Harvard Medical School, Boston, MA, USA
    Am J Psychiatry 164:929-35. 2007
    ..The purpose of this study was to characterize the course of 24 symptoms of borderline personality disorder in terms of time to remission...
  40. pmc Long-term anabolic-androgenic steroid use is associated with left ventricular dysfunction
    Aaron L Baggish
    Division of Cardiology, Massachusetts General Hospital, and Department of Medicine, Harvard Medical School, Boston, Mass 02114, USA
    Circ Heart Fail 3:472-6. 2010
    ..We compared cardiac parameters in weightlifters reporting long-term AAS use to those in otherwise similar weightlifters without prior AAS exposure...
  41. ncbi Pharmacologic treatment of binge eating disorder
    William P Carter
    Biological Psychiatry Laboratory, McLean Hospital, Belmont, MA 02478, USA
    Int J Eat Disord 34:S74-88. 2003
    ..To review the findings from pharmacologic trials of binge eating disorder (BED) and to provide guidelines for pharmacologic treatment...
  42. ncbi Familiality and heritability of binge eating disorder: results of a case-control family study and a twin study
    Kristin N Javaras
    Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, USA
    Int J Eat Disord 41:174-9. 2008
    ..To estimate the familiality and heritability of binge eating disorder (BED)...
  43. ncbi Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo-controlled clinical trials
    James I Hudson
    McLean Hospital, Belmont, MA, USA
    Hum Psychopharmacol 20:327-41. 2005
    ..To examine the safety and tolerability of the antidepressant duloxetine across multiple studies for major depressive disorder (MDD)...
  44. pmc The prevalence and correlates of binge eating disorder in the World Health Organization World Mental Health Surveys
    Ronald C Kessler
    Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA
    Biol Psychiatry 73:904-14. 2013
    ..Cross-national BED data are presented here and compared with bulimia nervosa (BN) data in the World Health Organization (WHO) World Mental Health Surveys...
  45. ncbi Early-onset cannabis use and cognitive deficits: what is the nature of the association?
    Harrison G Pope
    Department of Psychiatry, Harvard Medical School, McLean Hospital, 115 Mill Street, Belmont, MA 02478, USA
    Drug Alcohol Depend 69:303-10. 2003
    ..Individuals who initiate cannabis use at an early age, when the brain is still developing, might be more vulnerable to lasting neuropsychological deficits than individuals who begin use later in life...
  46. pmc Anabolic-androgenic steroid dependence: an emerging disorder
    Gen Kanayama
    Biological Psychiatry Laboratory, McLean Hospital, Belmont, Massachusetts, and Department of Psychiatry, Harvard Medical School, Boston, MA, USA
    Addiction 104:1966-78. 2009
    ..Here we review the accumulating human and animal evidence showing that AAS may cause a distinct dependence syndrome, often associated with adverse psychiatric and medical effects...
  47. pmc Human growth hormone abuse in male weightlifters
    Brian P Brennan
    Biological Psychiatry Laboratory, McLean Hospital, Belmont, Massachusetts 02478, USA
    Am J Addict 20:9-13. 2011
    ..These findings suggest that among young male weightlifters, illicit HGH use has become a common form of substance abuse, frequently associated with both AAS dependence and classical substance dependence. ..
  48. pmc Family study of borderline personality disorder and its sectors of psychopathology
    John G Gunderson
    The Borderline Center, McLean Hospital, Belmont, MA 02478
    Arch Gen Psychiatry 68:753-62. 2011
    ..The familiality of borderline personality disorder (BPD) and its sectors of psychopathology are incompletely understood...
  49. pmc Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern?
    Gen Kanayama
    Biological Psychiatry Laboratory, McLean Hospital Harvard Medical School, 115 Mill Street, Belmont, MA 02478, United States
    Drug Alcohol Depend 98:1-12. 2008
    ..The senior members of this population are now entering middle age; they represent the leading wave of a new type of aging former substance abusers, with specific medical and psychiatric risks...
  50. pmc A diagnostic interview module for anabolic-androgenic steroid dependence: preliminary evidence of reliability and validity
    Harrison G Pope
    Biological Psychiatry Laboratory, McLean Hospital, Belmont, Massachusetts 02478, USA
    Exp Clin Psychopharmacol 18:203-13. 2010
    ..Collectively, these findings suggest that AAS dependence may be diagnosed reliably, with preliminary evidence for construct and discriminant validity...
  51. ncbi Risk factors for anabolic-androgenic steroid use among weightlifters: a case-control study
    Gen Kanayama
    Biological Psychiatry Laboratory, McLean Hospital, 115 Mill Street, Belmont, MA 02478, USA
    Drug Alcohol Depend 71:77-86. 2003
    ..These findings suggest that AAS use may be most likely to occur in men with high levels of antisocial traits and low levels of body esteem...
  52. ncbi Is PTSD caused by traumatic stress?
    J Alexander Bodkin
    Clinical Psychopharmacology Research Program, McLean Hospital, Belmont, MA 02478, USA
    J Anxiety Disord 21:176-82. 2007
    ..This equivalence suggests that in a treatment-seeking population, caution should be exercised in attributing the PTSD syndrome to trauma...
  53. ncbi Anabolic steroid users' attitudes towards physicians
    Harrison G Pope
    Biological Psychiatry Laboratory, McLean Hospital Harvard Medical School, Belmont, MA 02478, USA
    Addiction 99:1189-94. 2004
    ..To assess anabolic-androgenic steroid (AAS) users' trust in the knowledge and advice of physicians...
  54. pmc Illicit anabolic-androgenic steroid use
    Gen Kanayama
    Biological Psychiatry Laboratory, McLean Hospital, Belmont, and Harvard Medical School, Boston, MA 02478, USA
    Horm Behav 58:111-21. 2010
    ..Finally, AAS may cause a dependence syndrome in a substantial minority of users. AAS dependence may pose a growing public health problem in future years but remains little studied...
  55. pmc Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole
    Brian P Brennan
    Biological Psychiatry Laboratory, McLean Hospital, Belmont, MA 02478, USA
    Neuropsychopharmacology 35:834-46. 2010
    ..Further investigation of the Gln/Glu ratio as a possible early biomarker of response to glutamate-modulating therapies is warranted...
  56. ncbi Psychological and cognitive effects of long-term peyote use among Native Americans
    John H Halpern
    Biological Psychiatry Laboratory, Alcohol and Drug Abuse Research Center, Harvard Medical School, McLean Hospital, 115 Mill Street, Belmont, MA 02478, USA
    Biol Psychiatry 58:624-31. 2005
    ..However, the long-term residual psychological and cognitive effects of hallucinogens remain poorly understood...
  57. pmc Anabolic steroid abuse among teenage girls: an illusory problem?
    Gen Kanayama
    Biological Psychiatry Laboratory, McLean Hospital Harvard Medical School, 115 Mill Street, Belmont, MA 02478, USA
    Drug Alcohol Depend 88:156-62. 2007
    ..We questioned whether AAS use among teenage girls was as widespread as claimed...
  58. ncbi Borderline psychopathology in the first-degree relatives of borderline and axis II comparison probands
    Mary C Zanarini
    The Laboratory for the Study for Adult Development, McLean Hospital, and the Department of Psychiatry, Harvard Medical School, Belmont, MA 02478, USA
    J Pers Disord 18:439-47. 2004
    ..Taken together, the results of this study suggest that the subsyndromal phenomenology of BPD may be more common than the borderline diagnosis itself...
  59. ncbi Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs
    John H Halpern
    Alcohol and Drug Abuse Research Center, Harvard Medical School, Biological Psychiatry Laboratory, McLean Hospital, 115 Mill Street, Belmont, MA 02478 9106, USA
    Drug Alcohol Depend 75:135-47. 2004
    ..Most MDMA users, however, use other illicit drugs as well, so it is difficult to be certain that these deficits are due to MDMA, as opposed to other drug use or additional confounding factors...
  60. ncbi Response to R. E. Goldsmith, R. E. Cheit, & m. E. Wood, "evidence of dissociative amnesia in science and literature: culture-bound approaches to trauma in pope et Al. (2007)"
    Harrison G Pope
    Department of Psychiatry, Harvard Medical School and Biological Psychiatry Laboratory, McLean Hospital, Belmont, Massachusetts, USA
    J Trauma Dissociation 10:254-7. 2009
    ..We invite interested readers first to review the issues of misinterpretation discussed by McNally and then to carefully compare the methodological discussion in our original paper with that of Goldsmith and colleagues...
  61. ncbi A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia
    Lesley M Arnold
    Women s Health Research Program, Department of Psychiatry, University of Cincinnati Medical Center, Cincinnati, Ohio 45267 0559, USA
    Am J Med 112:191-7. 2002
    ..To assess the efficacy of fluoxetine in the treatment of patients with fibromyalgia...
  62. ncbi Is dissociative amnesia a culture-bound syndrome? Findings from a survey of historical literature
    Harrison G Pope
    Biological Psychiatry Laboratory, McLean Hospital, Belmont, MA 02478, USA
    Psychol Med 37:225-33. 2007
    ..We asked whether 'dissociative amnesia' was similarly documented throughout history...
  63. ncbi Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial
    Harrison G Pope
    Biological Psychiatry Laboratory, McLean Hospital, 115 Mill St, Belmont, MA 02478 9106, USA
    Am J Psychiatry 160:105-11. 2003
    ..In an 8-week randomized, placebo-controlled trial, the authors administered a testosterone transdermal gel to men aged 30-65 who had refractory depression and low or borderline testosterone levels...
  64. ncbi Family studies of borderline personality disorder: a review
    Candace N White
    McLean Hospital, Belmont, Mass 02478, USA
    Harv Rev Psychiatry 11:8-19. 2003
    ..Because of significant methodological problems, most notably indirect assessments and inadequate sample size, major questions persist about the familial aggregation of this disorder that require more definitive methods...
  65. ncbi Tracking scientific interest in the dissociative disorders: a study of scientific publication output 1984-2003
    Harrison G Pope
    Biological Psychiatry Laboratory, McLean Hospital, and Department of Psychiatry, Harvard Medical School, Belmont, MA 02478, USA
    Psychother Psychosom 75:19-24. 2006
    ..We attempted to track scientific interest in dissociative amnesia and dissociative identity disorder by estimating the annual output of publications regarding these entities over the last 20 years...
  66. ncbi Cognitive measures in long-term cannabis users
    Harrison G Pope
    Biological Psychiatry Laboratory, McLean Hospital Harvard Medical School, Belmont, Massachusetts 02478, USA
    J Clin Pharmacol 42:41S-47S. 2002
    ....
  67. ncbi Body fat perception in eating-disordered men
    Barbara Mangweth
    Department of Psychiatry, University Clinics Innsbruck, Anichstr 35, A 6020, Austria
    Int J Eat Disord 35:102-8. 2004
    ..We sought to assess the relative roles of body fat ideals and body fat perception in men with eating disorders...
  68. ncbi Family study of fibromyalgia
    Lesley M Arnold
    University of Cincinnati College of Medicine, Cincinnati, Ohio 45267 0559, USA
    Arthritis Rheum 50:944-52. 2004
    ..To assess for familial aggregation of fibromyalgia (FM) and measures of tenderness and pain, and for familial coaggregation of FM and major mood disorder (major depressive disorder or bipolar disorder)...
  69. ncbi Comment on: Familial aggregation of depression in fibromyalgia: a community-based test of alternative hypotheses, Raphael et al., Pain 110 (2004) 449-460
    Lesley M Arnold
    Pain 112:409-10; author reply 410. 2004
  70. ncbi Outcomes of surgical management of total HIP replacement in patients aged 65 years and older: cemented versus cementless femoral components and lateral or anterolateral versus posterior anatomical approach
    Sheryl Zimmerma
    Cecil G Sheps Center for Health Services Research, The University of North Carolina at Chapel Hill, 27599 7590, USA
    J Orthop Res 20:182-91. 2002
    ....
  71. ncbi Childhood body-focused behaviors and social behaviors as risk factors of eating disorders
    Barbara Mangweth
    Department of Psychiatry, Innsbruck University Hospitals, Innsbruck, Austria
    Psychother Psychosom 74:247-53. 2005
    ..Therefore, we assessed a variety of childhood body-focused behaviors and childhood social behaviors in eating-disordered patients as compared to non-eating-disordered subjects...